StonkScan
OverviewRevenueFinancialsValuationOutlookOwnership
Price
Performance · vs S&P 500
Company
Analog Devices, Inc.
NASDAQ · USD
Large cap
0.90× peer median
0.87× peer median
21% more volatile
Claude reads this page's data and writes up Analog Devices, Inc.'s financials, valuation and analyst coverage: built only from the figures here, with nothing pulled in from elsewhere.
Generated by an AI model from the data on this page. It can be wrong, and it isn't investment advice or a recommendation to buy or sell anything. Check every figure against the sections themselves before you rely on it.
$4.9B of net debt against $4.8B of annual operating cash flow.
Liquidity · FY25
$7.3B in FY21 to $11.0B in FY25, with the latest year up 16.9%.
Growth · FY25
Free cash flow of $4.3B covers the business without outside capital, on $3.7B of cash and short-term investments.
Liquidity · FY25
$7.1B of current assets against $3.2B due within a year.
Liquidity · FY25
$11.0B of revenue against $8.1B of operating costs, leaving $2.9B.
Profitability · FY25
23.1% in FY21 to 26.6% in FY25.
Profitability · FY25
$17.1B of free cash flow against $11.4B of net income across 5 fiscal years.
Quality · FY25
Revenue came in above consensus by 2.4% on average over the last four reports.
Quality · Aug '26
AI strength, recovery in auto and industrial are driving growth in the Analog/Mixed-signal industry. MTSI, MPWR and SMTC are riding these trends.
The average of price targets set by Wall Street analysts indicates a potential upside of 28% in Analog Devices (ADI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Semiconductor stocks are falling at Tuesday's open as a global bond selloff drives long-term yields higher and forces a rethink of the market's highest-multiple corners.
Beacon Pointe Advisors LLC acquired a new position in Analog Devices, Inc. (NASDAQ: ADI) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 16,536 shares of the semiconductor company's stock, valued at approximately $6,568,000. Several other institutional
Humanoid robots could soon cost less than factory labor, opening a Physical AI market across chips, sensors, motors, and software.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for ADI-212 for the treatment of patients with metastatic castration-resistant prostate cancer (m.
Average month-end to month-end move for ADIin each calendar month. Point at a bar for that month's spread: past seasonality is a tendency in a small sample, not a forecast.
+$1.6B vs FY24
FY24 → FY25
FY21 → FY25, annualized
+33.6% vs the four before
Q3 FY26 · +39.6% YoY
Share of the latest fiscal year, largest first. The line is the segment across every fiscal year we have: hover it to read one.
What each segment added to or took off the top line in dollars: ranked by the size of the move, not its percentage.
+16.9% YoY
+4.4 pp YoY
+5.0 pp YoY
+38.6% YoY
+3.2 pp YoY
+39.1% YoY
+37.0% YoY
+$279M YoY
| $ billions | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Cash & equivalents | 2.5 | 2.0 | 1.0 | 1.5 | 2.0 |
| Short-term investments | 1.2 | 0.4 | 0.0 | 0.0 | 0.0 |
| Receivables | 1.4 | 1.3 | 1.5 | 1.8 | 1.5 |
| $ billions | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Operating cash flow | 4.8 | 3.9 | 4.8 | 4.5 | 2.7 |
| Capital expenditure | −0.5 | −0.7 | −1.3 | −0.7 | −0.3 |
| Free cash flow | 4.3 | 3.1 | 3.6 |
P/E vs EPS growth · below the channel = cheaper for its growth
P/S vs revenue growth · below the channel = cheaper for its growth
| Ticker | P/E | Fwd P/E | PEG | P/S | Fwd P/S | PSG | EPS gr | Rev gr |
|---|---|---|---|---|---|---|---|---|
| ADI | 42.1 | 27.7 | 0.44 | 12.5 | 11.5 | 0.50 | 62% | 23% |
| DELL | 29.4 | 20.3 | 0.34 | 2.3 | 1.8 | 0.06 | 59% | 32% |
| TXN | 38.4 | 29.8 | 0.99 | 11.9 | 10.6 | 0.66 | 30% | 16% |
| KLAC | 46.9 | 31.5 | 1.08 | 16.6 | 12.5 | 0.57 | 29% | 22% |
| MRVL | 68.5 | 49.8 | 1.03 | 19.4 | 15.3 | 0.33 | 48% | 46% |
| CDNS | 60.3 | 37.4 | 0.97 | 14.4 | 13.3 | 0.90 | 39% | 15% |
No report scheduled.
Dots = reported EPS vs consensus · gap = surprise · dashed = estimate ($)
Solid = reported · dashed = forward consensus · shaded = analyst low–high ($B)
Rows: discount rate (r) · Columns: terminal growth (g∞) · cell = fair value, shaded by up/downside vs 357.
Last 12M · $4M bought · $22M sold · net −$18M
| Inventory |
|---|
| 1.7 |
| 1.4 |
| 1.6 |
| 1.4 |
| 1.2 |
| Total current assets | 7.1 | 5.5 | 4.4 | 4.9 | 5.4 |
|---|
| Property, plant & equipment | 3.3 | 3.4 | 3.2 | 2.4 | 2.0 |
|---|
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
|---|
| Other non-current assets | 37.6 | 39.3 | 41.2 | 42.8 | 44.8 |
|---|
| Total assets | 48.0 | 48.2 | 48.8 | 50.3 | 52.3 |
|---|
| Accounts payable | 0.5 | 0.5 | 0.5 | 0.6 | 0.4 |
|---|
| Short-term debt | 0.4 | 0.9 | 1.0 | 0.0 | 0.5 |
|---|
| Total current liabilities | 3.2 | 3.0 | 3.2 | 2.4 | 2.8 |
|---|
| Long-term debt | 8.1 | 6.6 | 5.9 | 6.5 | 6.3 |
|---|
| Total liabilities | 14.2 | 13.1 | 13.2 | 13.8 | 14.3 |
|---|
| Shareholders’ equity | 33.8 | 35.2 | 35.6 | 36.5 | 38.0 |
|---|
Fiscal year · latest five reported years
| 3.8 |
| 2.4 |
| Investing cash flow | −1.3 | −1.1 | −1.3 | −0.7 | 2.1 |
|---|
| Dividends paid | −1.9 | −1.8 | −1.7 | −1.5 | −1.1 |
|---|
| Share buybacks | −2.2 | −0.6 | −3.0 | −2.6 | −3.1 |
|---|
| Net debt issued / (repaid) | 1.0 | 0.6 | 0.5 | −0.2 | 0.3 |
|---|
| Financing cash flow | −3.0 | −1.7 | −4.1 | −4.3 | −4.0 |
|---|
| Net change in cash | 0.5 | 1.0 | −0.5 | −0.5 | 0.9 |
|---|
Fiscal year · outflows shown negative